Another Big Wedding for Pharma: Astellas Invests $4 Billion in OSI Pharmaceuticals Dowry

SUGAR LAND--May 24, 2010--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--Spring is in the air and the Pharmaceutical-Biotech Industry is celebrating its first major marriage of the season--that is, a merger and acquisition, for those less metaphorically inclined. After a rocky courtship lasting several months, one filled with possible threats and rival suitors, Japan's Astellas Pharmaceuticals Incorporated (TYO:4503) (Tokyo) found $4 billion to be the magic number to win OSI Pharmaceuticals (NASDAQ:OSIP) (Melville, New York).